Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trial In Progress
750 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc fusion protein in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 750 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc fusion protein in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers